`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4519
`Facsimile: 650.319.4573
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALS, INC.,
`Petitioner,
`
`Vv.
`
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner
`
`Case IPR2021-00881
`U.S. Patent No. 9,254,338 B2
`
`PATENT OWNER’S REGENERON PHARMACEUTICALS, INC.’S
`UPDATED POWEROF ATTORNEY
`FOR UNITED STATES PATENTNO. 9,254,338 B2
`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Regeneron Pharmaceuticals, Inc. hereby
`
`appoints the Practitioners associated with Arnold and Porter Kaye Scholer LLP
`
`(Customer Number 180441), including the following lead and backup counselasits
`
`attorneys to transact all business in the United States Patent & Trademark Office
`
`Associated with the inter partes review No. IPR2021-00881.
`
`
`
`
`
`
`
`Lead Counsel
`Deborah E. Fishman (Reg. No.
`48,621)
`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4519
`Facsimile: 650.319.4573
`Deboarh.Fishman@arnoldporter.com
`
`
`
`
`
`
`
`
`
`Daniel Reisner(pro hacvice to be
`applied for)
`Matthew M. Wilk (pro hac vice to be
`applied for)
`Arnold & Porter Kaye Scholer LLP
`=p
`
`Back-Up Counsel
`David A. Caine (Reg. No. 52,683)
`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4710
`Facsimile: 650.319.4573
`David.Caine@arnoldporter.com
`
`Victoria Reines (pro hac vice to be
`applied for)
`Jeremy Cobb(pro hac vice to be
`applied for)
`Arnold & Porter Kaye Scholer LLP
`601 Massachusetts Ave., N.W.
`Washington D.C. 20001
`Tel: 202.942.5000
`Fax: 202.942.5999
`Alice.Ho@arnoldporter.com
`Victoria.Reines@arnoldporter.com
`Jeremy.Cobb@arnoldporter.com
`
` Alice S. Ho (Lim. Rec. No. L1162)
`
`
`
`
`
`
`
`
`
`
`
`250 West 55th Street
`
`New York, New York 10019-9710
`
`
`Telephone: 212.836.8000
`Facsimile: 212.836.8689
`
`Daniel.Reisner@arnoldporter.com
`Matthew. Wilk@arnoldporter.com
`
`
`
`The individual signing below has authority to execute this documenton behalf
`
`of Patent Owner Regeneron Pharmaceuticals, Inc.
`
`by:PaapCBr——For Patent Owner Regépéron Pharmaceuticals, Inc.
`
`Name: Frank R. Cottingham, Ph.D., J.D.
`
`Title: Executive Director & Assistant General Counsel, Patents
`for Regeneron Pharmaceuticals, Inc.
`
`Dated: November 22, 2021
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that a copy of the foregoing PATENT OWNER’S
`
`POWER OF ATTORNEY wasserved on November 22, 2021, to the following
`
`CounselforPetitioner via e-mail at MYL_REG_IPR@rmmslegal.com:
`
`Paul J. Molino (Reg. No. 45,350)
`paul@rmmslegal.com
`William A. Rakoezy (pro hac vice to be filed)
`wrakoczy@rmmslegal.com
`Heinz J. Salmen (pro hac vice to be filed)
`hsalmen@rmmslegal.com
`Neil B. McLaughlin (Reg. No. 70,810)
`nmclaughlin@rmmslegal.com
`Rakoczy Molino Mazzochi Siwik LLP
`6 West HubbardStreet
`Chicago, IL 60654
`Telephone: (312) 222-6300
`Facsimile (312) 843-6260
`
`Attorneys for Petitioner Mylan Pharmaceuticals, Inc.
`
`/s/ Deborah E. Fishman
`Deborah E. Fishman (Reg. No. 48,621)
`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4519
`Facsimile: 650.319.4573
`Deboarh.Fishman@arnoldporter.com
`
`